A detailed history of Hughes Financial Services, LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Hughes Financial Services, LLC holds 22 shares of BEAM stock, worth $438. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22
Holding current value
$438
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 01, 2025

BUY
$19.53 - $34.09 $429 - $749
22 New
22 $388,000

Others Institutions Holding BEAM

About Beam Therapeutics Inc.


  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.4B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Hughes Financial Services, LLC Portfolio

Follow Hughes Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hughes Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hughes Financial Services, LLC with notifications on news.